Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 2 subfamily D member 3 (OR2D3) is a human protein encoded by the OR2D3 gene. It is part of the olfactory receptor family, which constitutes the largest group of G protein-coupled receptors (GPCRs) in the human genome[2][3][4]. OR2D3 shares the characteristic seven-transmembrane domain structure of GPCRs, allowing it to detect odorant molecules in the nasal epithelium and initiate neuronal responses resulting in the perception of smell[2][4][3]. Olfactory receptors, including OR2D3, are primarily responsible for odor recognition and G protein-mediated signal transduction[4][2][3]. There are no known direct links between OR2D3 and specific human diseases or therapeutics, and to date, there are no drugs or diagnostic biomarkers targeting this receptor. The nomenclature for olfactory receptor genes is species-specific and independent across organisms[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily D member 3 (OR2D3).